(NBIA), including
pantothenate kinase-associated neurodegeneration (PKAN) and infantile
neuroaxonal dystrophy (INAD)Susan Hayflick, MD,
FACMG
Molecular and Medical Genetics, Neurology and Pediatrics
Oregon Health & Science University, mail code L103a
3181 SW Sam Jackson Park Rd.
Portland, OR 97239
Phone: (503)494-6866
Fax: (503)494-4411
E-mail: hayflick at ohsu.edu
My laboratory has identified major genes for NBIA, including PANK2 and PLA2G6. Our research goals are to advance understanding of disease
pathogenesis in order to develop rational therapies. We seek patients with NBIA
for inclusion in this research.
Our studies are approved by the OHSU IRB and are NIH funded.
Go back to Child-Neuro Homepage
Go back to Clinical Studies Seeking Patients page
Last updated 18-July-2006.